This page features the latest news about the Eli Lilly and Co stock. Eli Lilly : More than one-half of patients with Crohn's disease treated with mirikizumab achieved clinical remission at one ...

Eli Lilly (NYSE:LLY) is making a $5.3 billion investment to expand manufacturing for its high-demand anti-obesity drug Zepbound ...

Among the largest underlying components of XLG, in trading today Berkshire Hathaway Inc New (Symbol: BRK.B) is up about 1.2%, Eli Lilly (Symbol: LLY) is up about 0.8%, and Qualcomm Inc (Symbol ...

Below is a chart showing AMGN's trailing twelve month trading history, with the $285 strike highlighted in orange: Eli Lilly (Symbol: LLY) saw options trading volume of 23,259 contracts ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of the cryo-electron microscopy (cryoEM) structure of BLX-7006, its ...

Eli Lilly & Co. closed 13.93% short of its 52-week high of $972.53, which the company reached on August 22nd.

My DCF analysis suggests that Eli Lilly's stock is 60% undervalued. Defensive healthcare stocks like Eli Lilly are favorable in the current uncertain macroenvironment, driven by tariff concerns ...

Parnassus Core Equity Fund sees Eli Lilly And Co. (NYSE:LLY) as a strong long-term investment due to its GLP-1 franchise and ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Eli Lilly (NYSE:LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday.  The ...